KMB vs NDRA · P/E 19, rev $20.06B vs P/E 0.0, $2.6M cap
Kimberly-Clark Corporation (KMB) versus ENDRA Life Sciences Inc (NDRA) — a side-by-side from cached financials, not a winner call.
Kimberly-Clark Corporation (KMB) is a household & personal products company listed on US.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Latest reported KMB revenue for 2024-12-31 was $20.06B. Net income was $2.58B. Revenue was down 1.8% from 2023-12-31 to 2024-12-31. KMB currently screens at market cap $32.88B and trailing P/E 19.2.
NDRA does not have a complete income-statement cache yet.
KMB currently screens at market cap $32.88B and trailing P/E 19.2. NDRA currently screens at market cap $2.6M and trailing P/E 0.0.
Not investment advice. Open the KMB and NDRA stock pages for the full models.
Not investment advice.